NI
National Institutes of Health Olao
United States

NOI - A Non-Invasive Prognostic Biomarker - Circul

Oct 13, 2026·SAM-66af16818b144456af1ddc0d52fc9378
Open
Services
Combined Synopsis
9 days left
PublishedDeadline
Oct 13, 2026Oct 23, 2026

Description

(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith the format in FAR Subpart 12.6, as supplemented with additional information includedin this notice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00007. This solicitation is issued as a Notice ofIntent (NOI) for a non-competitive combined synopsis/solicitation to award a contract orpurchase order without providing for full and open competition (including brand-name, ifapplicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to University of Alabama at Birmingham, 701 S 20th Street, Birmingham, AL 35294-0001-0001, for research support to develop and validate circulating cell-free DNA (cfDNA) as a blood-based biomarker of chlorine-induced acute lung injury, using the Matalon Laboratory's sole-source validated murine chlorine inhalation injury model, established mechanistic expertise, access to its actively enrolling aspiration pneumonitis biorepository (human proxy cohort), existing collaborative infrastructure with the NHLBI Laboratory of Precision Omics, and continuity with peer-reviewed federal funding (NIH R01 HL031197). These capabilities are not available from any other source and are essential to the project's feasibility. (iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv)The associated NAICS code is 541380, Testing Laboratories and Services, and the small business size standard is $19.0 million. This requirement is not set aside for small business.

Tender details

NI

National Institutes of Health Olao

United States

Notice type

Contract notice

Published

Oct 13, 2026

Deadline

Oct 23, 2026

Contract type

Services

Main activity

General public services

Solicitation no.

75N98027Q00007

NAICS

Testing laboratories (541380)

Contracting office

BETHESDA, MD

Contact

Documents

More tenders

About the contracting office

National Institutes of Health OLAO · Department of Health and Human Services

National Institutes of Health OLAO has 16 open solicitations on SAM.gov right now, and 14 of them close within 14 days. 6% are set aside for small business. This notice gives bidders a 10-day response window, with 9 days left.

Most common sectors at this office: Other services (6), Professional, scientific and technical services (5), Manufacturing (3).

All 16 open solicitations from National Institutes of Health OLAO
NOI - A Non-Invasive Prognostic Biomarker - Circul | Tendoer